Pacemaker Q&A

Artificial Intelligence Doctor

Q1. From the total pacemakers implantation in one year in the United States, what is the percentage of transvenous (traditional) versus leadless?

Around 200,000 pacemakers are implanted annually in the U.S. Among VVI implants, leadless devices rose from ~1% (2016) to ~43% by 2020. For all pacemakers (including dual-chamber and CRT), transvenous still predominates (>50%).

Q2. Pros and cons of the bicameral (dual-chamber) leadless pacemaker versus a traditional transvenous dual-chamber pacing system?

Leadless Pros: No pocket/leads, lower infection, better cosmetic outcome, avoids tricuspid crossing, promising AV synchrony.
Leadless Cons: Higher cost, limited long-term data, pericardial risk, retrieval more complex.
Transvenous Pros: Established reliability, lower cost, easy generator swap, decades of evidence.
Transvenous Cons: Pocket/lead infection risk, visible bump, tricuspid regurgitation, extraction hazards.